Anavex Life Sciences Corp. (AVXL)
After hours:
- Motley Fool
Anavex Life Sciences (AVXL) Q4 2021 Earnings Call Transcript
With us today is Dr. Christopher Missling, president and chief executive officer; and Sandra Boenisch, principal financial officer. Following management's remarks, there will be a question-and-answer session.
- GlobeNewswire
Anavex Life Sciences to Present at the 4th Annual Evercore ISI HealthCONx Conference
NEW YORK, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that its President and Chief Executive Officer, Christopher U. Missling, PhD, is scheduled to partic
- GlobeNewswire
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Year End Financial Results
Webcast and Conference Call Today at 4:30 p.m. Eastern TimeNEW YORK, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today reported financial results for its fiscal year ende
